Treatment of ulcerative colitis: Is 5-aminosalicylates acid necessary to be combined with biologic agents?
10.3760/cma.j.cn101480-20250324-00048
- VernacularTitle:治疗溃疡性结肠炎：5-氨基水杨酸是否需要与生物制剂联用
- Author:
Shuyi XIE
1
;
Min ZHI
;
Min ZHANG
Author Information
1. 中山大学附属第六医院消化内科，广州 510655
- Publication Type:Journal Article
- Keywords:
Ulcerative colitis;
5-aminosalicylates acid;
Biologic agents;
Combination therapy;
Step-up therapy
- From:
Chinese Journal of Inflammatory Bowel Diseases
2025;09(4):345-350
- CountryChina
- Language:Chinese
-
Abstract:
This article summarizes current research and real-world evidence on the combined use of 5-aminosalicylates acid (5-ASA) with biologic agents in ulcerative colitis (UC) patients undergoing step-up therapy. Furthermore, it explores the potential value of whether combination therapy or not in different clinical scenarios. The findings provide insights for personalized UC treatment strategies and suggest directions for future research.
